PRKDC and urinary bladder carcinoma: Thus both, the biallelic mutation in TP53 identified in all three cell lines, as well as the mono-allelic SNVs in PRKDC identified in SCaBER and J82 cells, reflect typical and frequent alterations of bladder cancers.